Status:
TERMINATED
HEROIC (Heparin Requirement in Counterpulsation)
Lead Sponsor:
Corewell Health East
Conditions:
Cardiogenic Shock
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Patients with intra-aortic balloon pumps (catheters placed in the groin connected to a pump which assists the heart by opening and closing a balloon in the aorta, thereby decreasing the work of the he...
Detailed Description
Potential patients will be identified in the cardiac catheterization lab when an intra-aortic balloon pump is placed. Patients who agree to participate in this study will be randomized (they will be s...
Eligibility Criteria
Inclusion
- Age \>/= 18 years
- Able to provide consent
- Insertion of Intra-aortic Balloon Pump (IABP) in William Beaumont Hospital (WBH) cath lab
- Anticipated duration of IABP \>/= 18 hours
Exclusion
- Contraindications to heparin
- Pre-existing condition requiring heparin administration (other than IABP)
- IABP placed outside of the WBH cardiac catheterization lab prophylactically for high-risk percutaneous coronary intervention (PCI), without complications)
- Pregnant women
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00445211
Start Date
January 1 2006
End Date
March 1 2008
Last Update
May 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073